# FDA recall D-002-2014

> **Boehringer Ingelheim Roxane Inc** · Class II · drug recall initiated 2013-04-03.

## Product

Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59

## Reason for recall

Resuspension Problems: Recalled lot did not meet resuspendability requirements.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-002-2014
- **Recalling firm:** Boehringer Ingelheim Roxane Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-03
- **Report date:** 2013-11-27
- **Termination date:** 2014-02-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-002-2014

## Citation

> AI Analytics. FDA recall D-002-2014. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-002-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*